DealsBiogen to acquire Jeito Capital-backed biopharma company HI-Bio for $1.15bnBiogen is a Cambridge, Massachusetts-based biotech firm.ByIris Dorbian22 May 2024•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs